Page last updated: 2024-09-04

ampelopsin and Neointima

ampelopsin has been researched along with Neointima in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Huang, B; Li, Y; Shu, W; Yao, Y	1

Other Studies

1 other study(ies) available for ampelopsin and Neointima

Article	Year
Dihydromyricetin from ampelopsis grossedentata protects against vascular neointimal formation via induction of TR3. European journal of pharmacology, 2018, Nov-05, Volume: 838 Topics: Ampelopsis; Animals; Carotid Arteries; Carotid Stenosis; Cell Line; Cell Proliferation; Disease Models, Animal; Flavonols; Humans; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Nuclear Receptor Subfamily 4, Group A, Member 1; Rats	2018

Article

Year

Dihydromyricetin from ampelopsis grossedentata protects against vascular neointimal formation via induction of TR3.

European journal of pharmacology, 2018, Nov-05, Volume: 838

Topics: Ampelopsis; Animals; Carotid Arteries; Carotid Stenosis; Cell Line; Cell Proliferation; Disease Models, Animal; Flavonols; Humans; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Nuclear Receptor Subfamily 4, Group A, Member 1; Rats

2018